Savara Inc.
SVRA
Rank in Stocks
#8515
Savara Inc. is a biopharmaceutical firm in the clinical development phase,... Savara Inc. is a biopharmaceutical firm in the clinical development phase, specializing in therapies for uncommon respiratory conditions. Their primary investigational drug, molgramostim, is an inhaled form of granulocyte-macrophage colony-stimulating factor (GM-CSF). This compound is currently undergoing Phase III trials to address autoimmune pulmonary alveolar proteinosis. The company's main operations are situated in Austin, Texas.
Share Price
$5.05
Last synced: 2026-11-09
Market Cap
$1.04B
Change (1 day)
4.55%
Change (1 year)
18.54%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Savara Inc. (SVRA)
Category
Healthcare
Operating Margin for Savara Inc. (SVRA)
Operating Margin as of November 2026 TTM: 0.00%
According to Savara Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Savara Inc. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | -100.00% |
| 2020 | -19,182.88% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | -100.00% |
| 2016 | -2,737.00% | -100.00% |
| 2015 | -72,912,962.96% | 3,754.96% |
| 2014 | -1,891,408.27% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | 0.00% |
| 2011 | 0.00% | -100.00% |
| 2010 | -1,746.51% | -53.57% |
| 2009 | -3,761.90% | -31.13% |
| 2008 | -5,461.97% | 12.34% |
| 2007 | -4,862.21% | 0.00% |
| 2006 | 0.00% | -100.00% |
| 2005 | -2,661.58% | 0.00% |
| 2004 | 0.00% | 0.00% |
| 2003 | 0.00% | 0.00% |
| 2002 | 0.00% | 0.00% |
| 2001 | 0.00% | 0.00% |
| 2000 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Savara Inc.'s operating margin
What was Savara Inc.'s operating margin in 2025?
In 2025, Savara Inc.'s operating margin was 0.00%, compared with 0.00% in 2024.
How has Savara Inc.'s operating margin changed since 2020?
From 2020 to 2025, Savara Inc.'s operating margin was highest in 2025 (0.00%) and lowest in 2020 (-19,182.88%).
How does Savara Inc.'s operating margin compare with similar companies?
Savara Inc.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.